BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30685832)

  • 1. Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; de Vet HCW; Coupé VMH
    J Cancer Educ; 2020 Apr; 35(2):345-351. PubMed ID: 30685832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision support systems for incurable non-small cell lung cancer: a systematic review.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; Jansma EP; De Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):144. PubMed ID: 28969629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-Line Treatment Selection in Patients With Non-Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians.
    Girard N; Corral J; Cortinovis D; Heigener DF
    Clin Lung Cancer; 2017 Mar; 18(2):e89-e97. PubMed ID: 27865625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical decision support needs assessment of community-based physicians.
    Richardson JE; Ash JS
    J Am Med Inform Assoc; 2011 Dec; 18 Suppl 1(Suppl 1):i28-35. PubMed ID: 21890874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer treatment in New Zealand: physician's attitudes.
    Christmas T; Findlay M
    N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making.
    Pardon K; Deschepper R; Stichele RV; Bernheim JL; Mortier F; Bossuyt N; Schallier D; Germonpré P; Galdermans D; Van Kerckhoven W; Deliens L;
    J Palliat Med; 2010 Oct; 13(10):1199-203. PubMed ID: 20849278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non-small cell lung cancer patients at a lung cancer center in China.
    Yao S; Wang R; Qian K; Zhang Y
    Thorac Cancer; 2020 May; 11(5):1265-1270. PubMed ID: 32191394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
    Evison M; Edwards J; McDonald F; Popat S
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):527-536. PubMed ID: 32216979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
    Schmalz O; Jacob C; Ammann J; Liss B; Iivanainen S; Kammermann M; Koivunen J; Klein A; Popescu RA
    J Med Internet Res; 2020 Dec; 22(12):e18655. PubMed ID: 33346738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.
    Mokhles S; Nuyttens JJME; de Mol M; Aerts JGJV; Maat APWM; Birim Ö; Bogers AJJC; Takkenberg JJM
    BMC Cancer; 2018 Jan; 18(1):79. PubMed ID: 29334910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
    Wu SY; Lazar AA; Gubens MA; Blakely CM; Gottschalk AR; Jablons DM; Jahan TM; Wang VEH; Dunbar TL; Wong ML; Chan JW; Guthrie W; Belkora J; Yom SS
    JAMA Netw Open; 2020 Sep; 3(9):e209750. PubMed ID: 32997124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dumping the information bucket: A qualitative study of clinicians caring for patients with early stage non-small cell lung cancer.
    Golden SE; Thomas CR; Moghanaki D; Slatore CG;
    Patient Educ Couns; 2017 May; 100(5):861-870. PubMed ID: 28034611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC.
    Cramer-van der Welle CM; Kastelijn EA; Plouvier BC; van Uden-Kraan CF; Schramel FMNH; Groen HJM; van de Garde EMW
    JCO Clin Cancer Inform; 2021 May; 5():570-578. PubMed ID: 34010031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.
    Cotarla I; Boron ML; Cullen SL; Spinner DS; Faulkner EC; Carroll MC; Shah S; Yagui-Beltran A
    JCO Oncol Pract; 2020 Oct; 16(10):e1232-e1242. PubMed ID: 32552457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life.
    Park R; Shaw JW; Korn A; McAuliffe J
    J Cancer Surviv; 2020 Jun; 14(3):363-376. PubMed ID: 31950409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition).
    Socinski MA; Crowell R; Hensing TE; Langer CJ; Lilenbaum R; Sandler AB; Morris D;
    Chest; 2007 Sep; 132(3 Suppl):277S-289S. PubMed ID: 17873174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer.
    Schroen AT; Detterbeck FC; Crawford R; Rivera MP; Socinski MA
    Chest; 2000 Jul; 118(1):129-37. PubMed ID: 10893370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.